Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VRDN - Viridian Therapeutics, Inc.\DE


IEX Last Trade
19.46
0   0%

Share volume: 23,820
Last Updated: Fri 27 Dec 2024 08:30:23 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): 0.25%

PREVIOUS CLOSE
CHG
CHG%

$19.46
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-15 2022-11-14 2023-03-09 2023-05-10 2023-08-08 2023-11-13 2024-02-27 2024-05-08
Assets
Total Assets 169.814 M 440.580 M 435.091 M 386.642 M 351.467 M 328.757 M 490.424 M 630.381 M
Current Assets 166.151 M 437.355 M 431.173 M 382.602 M 346.331 M 323.839 M 486.478 M 626.818 M
Inventories 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Other Current Assets 4.251 M 5.635 M 6.521 M 8.616 M 11.938 M 10.730 M 9.006 M 13.529 M
Short Term Investments 4.251 M 5.635 M 6.521 M 8.616 M 11.938 M 10.730 M 9.006 M 13.529 M
Total Receivables 693.000 K 398.000 K 102.000 K 128.000 K 102.000 K 102.000 K 102.000 K 102.000 K
Current Cash 161.207 M 431.322 M 424.550 M 373.858 M 334.291 M 313.007 M 477.370 M 613.187 M
Total Non-current Assets 3.663 M 3.225 M 3.918 M 4.040 M 5.136 M 4.918 M 3.946 M 3.563 M
Property Plant Equipment 749.000 K 825.000 K 1.326 M 1.590 M 1.882 M 1.800 M 1.672 M 1.526 M
Other Assets 2.914 M 2.400 M 2.592 M 2.450 M 3.254 M 3.118 M 2.274 M 2.037 M
Intangible Assets 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Goodwill 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Liabilities and shareholders’ equity
Total Liabilities and shareholders’ equity 169.814 M 440.580 M 435.091 M 386.642 M 351.467 M 328.757 M 490.424 M 630.381 M
Total liabilities 27.916 M 31.573 M 40.027 M 36.093 M 35.610 M 45.181 M 48.402 M 47.851 M
Total current liabilities 21.388 M 25.214 M 33.349 M 29.588 M 28.657 M 23.247 M 26.635 M 26.127 M
Accounts Payable 4.061 M 12.152 M 14.234 M 7.872 M 4.133 M 3.735 M 2.239 M 2.676 M
Other liabilities 1.943 M 1.746 M 2.033 M 1.828 M 2.244 M 1.934 M 1.562 M 1.396 M
Current long term debt 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Long term debt 4.585 M 4.613 M 4.645 M 4.677 M 4.709 M 20.000 M 20.205 M 20.328 M
Other liabilities 1.943 M 1.746 M 2.033 M 1.828 M 2.244 M 1.934 M 1.562 M 1.396 M
Minority interest 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Total Shareholder equity 141.898 M 409.007 M 395.064 M 350.549 M 315.857 M 283.576 M 442.022 M 582.530 M
Common stock 27.762 M 33.742 M 40.719 M 42.242 M 43.253 M 43.655 M 49.872 M 61.099 M
Retained earnings -413.484 M -442.389 M -488.174 M -556.325 M -611.388 M -659.048 M -725.908 M -774.450 M